SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-23-272401
Filing Date
2023-11-07
Accepted
2023-11-07 16:01:50
Documents
48
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q d529509d10q.htm   iXBRL 10-Q 1131740
2 EX-31.1 d529509dex311.htm EX-31.1 10761
3 EX-31.2 d529509dex312.htm EX-31.2 10766
4 EX-32.1 d529509dex321.htm EX-32.1 5124
  Complete submission text file 0001193125-23-272401.txt   5049861

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA cbay-20230930.xsd EX-101.SCH 38631
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cbay-20230930_cal.xml EX-101.CAL 26682
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cbay-20230930_def.xml EX-101.DEF 160298
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE cbay-20230930_lab.xml EX-101.LAB 292668
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cbay-20230930_pre.xml EX-101.PRE 219048
42 EXTRACTED XBRL INSTANCE DOCUMENT d529509d10q_htm.xml XML 863823
Mailing Address 7575 GATEWAY BOULEVARD SUITE 110 NEWARK CA 94560
Business Address 7575 GATEWAY BOULEVARD SUITE 110 NEWARK CA 94560 510-293-8800
CymaBay Therapeutics, Inc. (Filer) CIK: 0001042074 (see all company filings)

IRS No.: 943103561 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36500 | Film No.: 231383559
SIC: 2834 Pharmaceutical Preparations